Allstate (NYSE:ALL) Price Target Raised to $235.00
by Teresa Graham · The Cerbat GemAllstate (NYSE:ALL – Free Report) had its price objective raised by Morgan Stanley from $225.00 to $235.00 in a report published on Tuesday,Benzinga reports. They currently have an overweight rating on the insurance provider’s stock.
A number of other research analysts also recently weighed in on ALL. Keefe, Bruyette & Woods cut their price objective on Allstate from $240.00 to $228.00 and set an “outperform” rating on the stock in a research note on Wednesday, April 9th. StockNews.com upgraded shares of Allstate from a “hold” rating to a “buy” rating in a research note on Thursday, May 1st. Argus upgraded shares of Allstate from a “hold” rating to a “buy” rating in a report on Monday, March 3rd. Barclays lowered their price target on Allstate from $183.00 to $172.00 and set an “underweight” rating on the stock in a research report on Friday, April 11th. Finally, Evercore ISI boosted their price objective on Allstate from $227.00 to $230.00 and gave the stock an “outperform” rating in a research report on Thursday, May 1st. One investment analyst has rated the stock with a sell rating, one has given a hold rating, fourteen have assigned a buy rating and one has given a strong buy rating to the company’s stock. Based on data from MarketBeat, the stock currently has a consensus rating of “Moderate Buy” and a consensus target price of $224.73.
Get Our Latest Research Report on Allstate
Allstate Price Performance
Shares of ALL opened at $202.42 on Tuesday. The company has a debt-to-equity ratio of 0.42, a quick ratio of 0.40 and a current ratio of 0.36. The firm has a market cap of $53.67 billion, a PE ratio of 11.91, a PEG ratio of 1.01 and a beta of 0.32. The firm’s 50 day moving average price is $198.88 and its 200 day moving average price is $194.95. Allstate has a twelve month low of $156.66 and a twelve month high of $212.91.
Allstate (NYSE:ALL – Get Free Report) last released its quarterly earnings data on Wednesday, April 30th. The insurance provider reported $3.53 earnings per share (EPS) for the quarter, missing the consensus estimate of $3.98 by ($0.45). The business had revenue of $14.30 billion during the quarter, compared to analyst estimates of $16.41 billion. Allstate had a net margin of 7.28% and a return on equity of 28.20%. The firm’s revenue for the quarter was up 7.8% on a year-over-year basis. During the same period in the previous year, the firm posted $5.13 EPS. As a group, research analysts expect that Allstate will post 18.74 EPS for the current fiscal year.
Allstate declared that its board has approved a share repurchase program on Wednesday, February 26th that allows the company to buyback $1.50 billion in shares. This buyback authorization allows the insurance provider to repurchase up to 3% of its shares through open market purchases. Shares buyback programs are often a sign that the company’s board believes its shares are undervalued.
Allstate Increases Dividend
The firm also recently declared a quarterly dividend, which was paid on Tuesday, April 1st. Shareholders of record on Monday, March 10th were paid a dividend of $1.00 per share. The ex-dividend date was Monday, March 10th. This represents a $4.00 dividend on an annualized basis and a yield of 1.98%. This is an increase from Allstate’s previous quarterly dividend of $0.92. Allstate’s payout ratio is currently 27.32%.
Insider Activity
In related news, CFO Jesse E. Merten sold 40,102 shares of the stock in a transaction dated Monday, February 10th. The shares were sold at an average price of $186.53, for a total value of $7,480,226.06. Following the completion of the transaction, the chief financial officer now owns 18,115 shares of the company’s stock, valued at $3,378,990.95. This represents a 68.88 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is available at this hyperlink. 1.80% of the stock is owned by company insiders.
Institutional Investors Weigh In On Allstate
Several large investors have recently modified their holdings of ALL. Bank of America Corp DE grew its position in Allstate by 157.9% in the fourth quarter. Bank of America Corp DE now owns 6,591,138 shares of the insurance provider’s stock valued at $1,270,705,000 after acquiring an additional 4,035,629 shares during the period. Norges Bank bought a new stake in shares of Allstate in the 4th quarter worth about $344,354,000. GQG Partners LLC increased its position in shares of Allstate by 64.1% during the 4th quarter. GQG Partners LLC now owns 4,316,516 shares of the insurance provider’s stock worth $832,181,000 after purchasing an additional 1,685,694 shares in the last quarter. GAMMA Investing LLC lifted its holdings in Allstate by 25,026.1% during the 1st quarter. GAMMA Investing LLC now owns 1,273,895 shares of the insurance provider’s stock valued at $263,785,000 after purchasing an additional 1,268,825 shares during the last quarter. Finally, Strategic Financial Concepts LLC boosted its position in Allstate by 15,062.3% in the fourth quarter. Strategic Financial Concepts LLC now owns 1,119,129 shares of the insurance provider’s stock valued at $215,757,000 after buying an additional 1,111,748 shares in the last quarter. 76.47% of the stock is currently owned by institutional investors.
Allstate Company Profile
The Allstate Corporation, together with its subsidiaries, provides property and casualty, and other insurance products in the United States and Canada. It operates in five segments: Allstate Protection; Protection Services; Allstate Health and Benefits; Run-off Property-Liability; and Corporate and Other segments.
Read More
- Five stocks we like better than Allstate
- How Can Retail Investors Trade the Toronto Stock Exchange (TSX)?
- 3 Mid-Cap Medical Stocks Outperforming the Market
- Stock Average Calculator
- The Top-Ranked Insider Buys From April by Market Cap
- 3 Dividend Kings To Consider
- Is Eli Lilly a Buy After Weak Earnings and CVS-Novo Partnership?